Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2009 4
2010 8
2011 6
2012 8
2013 3
2014 5
2015 2
2016 5
2017 5
2018 9
2019 14
2020 15
2021 8
2022 20
2023 22
2024 14
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
Personalized Therapy of Sarcomas.
Desar IME, Rothermundt C. Desar IME, et al. Cancers (Basel). 2023 Oct 23;15(20):5110. doi: 10.3390/cancers15205110. Cancers (Basel). 2023. PMID: 37894477 Free PMC article.
Reversible hypogammaglobulinaemia.
Desar IM, Weemaes CM, van Deuren M, van der Meer JW. Desar IM, et al. Neth J Med. 2007 Nov;65(10):381-5. Neth J Med. 2007. PMID: 18057460 Free article.
Systemic treatment in adult uterine sarcomas.
Desar IME, Ottevanger PB, Benson C, van der Graaf WTA. Desar IME, et al. Crit Rev Oncol Hematol. 2018 Feb;122:10-20. doi: 10.1016/j.critrevonc.2017.12.009. Epub 2017 Dec 14. Crit Rev Oncol Hematol. 2018. PMID: 29458779 Free article. Review.
Systemic Treatment for Adults with Synovial Sarcoma.
Desar IME, Fleuren EDG, van der Graaf WTA. Desar IME, et al. Curr Treat Options Oncol. 2018 Mar 7;19(2):13. doi: 10.1007/s11864-018-0525-1. Curr Treat Options Oncol. 2018. PMID: 29516254 Free PMC article. Review.
[Oncology at a glance].
Oskam KE, Veldhoven CMM, Desar IME. Oskam KE, et al. Among authors: desar ime. Ned Tijdschr Geneeskd. 2019 Jun 17;163:D3817. Ned Tijdschr Geneeskd. 2019. PMID: 31283114 Dutch.
Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses.
van Ravensteijn SG, de Haan JJ, Gelderblom H, Nederkoorn MJL, Hillebrandt-Roeffen MHS, Gorris MAJ, de Bitter TJJ, Boleij A, Gusinac A, Ederveen THA, Flucke UE, Bonenkamp JJ, Speetjens FM, Kaal SEJ, Smits M, Bol KF, van Herpen CML, Versleijen-Jonkers YMH, Desar IME. van Ravensteijn SG, et al. Among authors: desar ime. Clin Cancer Res. 2025 Sep 2;31(17):3678-3691. doi: 10.1158/1078-0432.CCR-25-0311. Clin Cancer Res. 2025. PMID: 40632032 Free PMC article. Clinical Trial.
Kidney injury during VEGF inhibitor therapy.
den Deurwaarder ES, Desar IM, Steenbergen EJ, Mulders PF, Wetzels JF, van Herpen CM. den Deurwaarder ES, et al. Among authors: desar im. Neth J Med. 2012 Aug;70(6):267-71. Neth J Med. 2012. PMID: 22859418 Free article. Review.
143 results